CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,698 | -43.3% | 116,562 | -35.8% | 0.00% | -42.9% |
Q4 2022 | $4,760 | -99.9% | 181,662 | -17.2% | 0.01% | +16.7% |
Q3 2022 | $4,312,000 | -9.7% | 219,342 | -19.6% | 0.01% | 0.0% |
Q2 2022 | $4,774,000 | +9.4% | 272,962 | +2.3% | 0.01% | +20.0% |
Q1 2022 | $4,364,000 | -27.4% | 266,742 | -27.6% | 0.01% | -28.6% |
Q4 2021 | $6,013,000 | -11.4% | 368,642 | -30.6% | 0.01% | -22.2% |
Q3 2021 | $6,783,000 | -25.5% | 531,562 | -17.6% | 0.01% | -18.2% |
Q2 2021 | $9,109,000 | -21.0% | 645,142 | -13.0% | 0.01% | -21.4% |
Q1 2021 | $11,528,000 | -13.1% | 741,842 | -11.3% | 0.01% | 0.0% |
Q4 2020 | $13,260,000 | – | 836,086 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |